EUVIMEDAtrasti EUVIMED
Crossref

Identification of atrial fibrillation phenotypes at low risk of stroke in patients with CHA2DS2‐VASc ≥2: Insight from the China‐AF study

Chao Jiang, Mingxiao Li, Yiying Hu, Xin Du, Xiang Li, Liu He, Yiwei Lai iD, Tiange Chen, Yingxue Li, Xueyuan Guo, Chenxi Jiang iD, Ribo Tang iD and 5 more

Pacing and Clinical Electrophysiology · 2023

DOI: 10.1111/pace.14829 ↗

At a glance

Journal article in Pacing and Clinical Electrophysiology, 2023. Written by Chao Jiang and 16 co-authors. Institution: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing…. Major MEDLINE topics: Atrial Fibrillation, Stroke. Cited 2 times so far (Crossref); 37 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, the Beijing Municipal Science and Technology Commission.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Objective

Patients with atrial fibrillation (AF) are highly heterogeneous, and current risk stratification scores are only modestly good at predicting an individual's stroke risk. We aim to identify distinct AF clinical phenotypes with cluster analysis to optimize stroke prevention practices.

Methods

From the prospective Chinese Atrial Fibrillation Registry cohort study, we included 4337 AF patients with CHA 2 DS 2 ‐VASc≥2 for males and 3 for females who were not treated with oral anticoagulation. We randomly split the patients into derivation and validation sets by a ratio of 7:3. In the derivation set, we used outcome‐driven patient clustering with metric learning to group patients into clusters with different risk levels of ischemic stroke and systemic embolism, and identify clusters of patients with low risks. Then we tested the results in the validation set, using the clustering rules generated from the derivation set. Finally, the survival decision tree was applied as a sensitivity analysis to confirm the results.

Results

Up to the follow‐up of 1 year, 140 thromboembolic events (ischemic stroke or systemic embolism) occurred. After supervised metric learning from six variables involved in CHA 2 DS 2 ‐VASc scheme, we identified a cluster of patients (255/3035, 8.4%) at an annual thromboembolism risk of 0.8% in the derivation set. None of the patients in the low‐risk cluster had prior thromboembolism, heart failure, diabetes, or age older than 70 years. After applying the regularities from metric learning on the validation set, we also identified a cluster of patients (137/1302, 10.5%) with an incident thromboembolism rate of 0.7%. Sensitivity analysis based on the survival decision tree approach selected a subgroup of patients with the same phenotypes as the metric‐learning algorithm.

Conclusions

Cluster analysis identified a distinct clinical phenotype at low risk of stroke among high‐risk [CHA 2 DS 2 ‐VASc≥2 (3 for females)] patients with AF. The use of the novel analytic approach has the potential to prevent a subset of AF patients from unnecessary anticoagulation and avoid the associated risk of major bleeding.

Subjects

MeSH terms (MEDLINE)

Atrial FibrillationStrokeHumansMaleFemaleAgedChinaRisk AssessmentPhenotypeProspective StudiesMiddle AgedRegistriesRisk Factors

Author keywords

atrial fibrillationclinical phenotypecluster analysisstroke

Authors and institutions

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
  • Ping An Health Technology, Beijing, China.
  • Heart Health Research Center, Beijing, China.
  • School of Public Health, Peking University Health Science Center, Beijing, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.

ORCID profiles: Yiwei Lai, Chenxi Jiang, Ribo Tang, Caihua Sang, Deyong Long, Changsheng Ma

Funding

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • the Beijing Municipal Science and Technology Commission
  • Beijing Municipal Education Commission
  • Bristol-Myers Squibb
  • Pfizer
  • Johnson & Johnson
  • Bayer

Cite

APA

Jiang, C., Li, M., Hu, Y., Du, X., Li, X., He, L., Lai, Y., Chen, T., Li, Y., Guo, X., Jiang, C., Tang, R., Sang, C., Long, D., Xie, G., Dong, J., & Ma, C. (2023). Identification of atrial fibrillation phenotypes at low risk of stroke in patients with CHA2DS2‐VASc ≥2: Insight from the China‐AF study. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14829

Vancouver

Jiang C, Li M, Hu Y, Du X, Li X, He L, et al. Identification of atrial fibrillation phenotypes at low risk of stroke in patients with CHA2DS2‐VASc ≥2: Insight from the China‐AF study. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14829

BibTeX
@article{Jiang2023,
  author = {Jiang, Chao and Li, Mingxiao and Hu, Yiying and Du, Xin and Li, Xiang and He, Liu and Lai, Yiwei and Chen, Tiange and Li, Yingxue and Guo, Xueyuan and Jiang, Chenxi and Tang, Ribo and Sang, Caihua and Long, Deyong and Xie, Guotong and Dong, Jianzeng and Ma, Changsheng},
  title = {Identification of atrial fibrillation phenotypes at low risk of stroke in patients with CHA2DS2‐VASc ≥2: Insight from the China‐AF study},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  doi = {10.1111/pace.14829}
}
Start for free →